Leonard S. Schleifer - Aug 18, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
President & CEO, Director
Signature
/s/**Leonard S. Schleifer
Stock symbol
REGN
Transactions as of
Aug 18, 2021
Transactions value $
-$136,606,300
Form type
4
Date filed
8/20/2021, 04:02 PM
Previous filing
Aug 17, 2021
Next filing
Nov 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$130M -200K -39.62% $650.03 305K Aug 18, 2021 Direct F1, F2
transaction REGN Common Stock Sale -$6.6M -10K -32.07% $660.03 21.2K Aug 19, 2021 By Trust F1, F3, F4
holding REGN Common Stock 200K Aug 18, 2021 2021 GRAT
holding REGN Common Stock 5.87K Aug 18, 2021 By 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 200,000 shares of Company stock on August 18, 2021 at prices ranging from $650.00 to $650.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 18, 2021 at each separate price.
F3 Represents volume-weighted average price of sales of 10,000 shares of Company stock on August 19, 2021 at prices ranging from $660.00 to $660.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 19, 2021 at each separate price.
F4 These shares are held in a trust for the benefit of the reporting person's family members. The reporting person's spouse is a trustee of the trust.